How We Work
The Aims Behind Our Success
Nov 2023
Company Established
2H 2024
Seek Funding Secured, Patent Approved
1H 2025
Qianhai Branch Established, Pre-clinical Data Consolidated
2H 2025
Research Team Formed, Series A Round for Translational Research
2026
CDMO, CRO, IIT for Pre-IND
2027
NMPA IND Approval, Clinical Trial I, Series B for Clinical Trials
2028
Clinical Trial II
2029
HKEX 18A Listing
2030
NMPA Fast Track, Commercialised Trial III
-
TOTAL VASCULAR SOLUTION
-
TOTAL VASCULAR SOLUTION
-
TOTAL VASCULAR SOLUTION
-
TOTAL VASCULAR SOLUTION
-
TOTAL VASCULAR SOLUTION
-
TOTAL VASCULAR SOLUTION
-
TOTAL VASCULAR SOLUTION
-
TOTAL VASCULAR SOLUTION
-
TOTAL VASCULAR SOLUTION
-
TOTAL VASCULAR SOLUTION
-
TOTAL VASCULAR SOLUTION
-
TOTAL VASCULAR SOLUTION